Stoke Change To Netincome vs Net Income Analysis

STOK Stock  USD 13.26  0.50  3.63%   
Stoke Therapeutics financial indicator trend analysis is much more than just breaking down Stoke Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Stoke Therapeutics is a good investment. Please check the relationship between Stoke Therapeutics Change To Netincome and its Net Income accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.

Change To Netincome vs Net Income

Change To Netincome vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Stoke Therapeutics Change To Netincome account and Net Income. At this time, the significance of the direction appears to have pay attention.
The correlation between Stoke Therapeutics' Change To Netincome and Net Income is -0.98. Overlapping area represents the amount of variation of Change To Netincome that can explain the historical movement of Net Income in the same time period over historical financial statements of Stoke Therapeutics, assuming nothing else is changed. The correlation between historical values of Stoke Therapeutics' Change To Netincome and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Netincome of Stoke Therapeutics are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Change To Netincome i.e., Stoke Therapeutics' Change To Netincome and Net Income go up and down completely randomly.

Correlation Coefficient

-0.98
Relationship DirectionNegative 
Relationship StrengthSignificant

Change To Netincome

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Stoke Therapeutics financial statement analysis. It represents the amount of money remaining after all of Stoke Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most indicators from Stoke Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Stoke Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.Issuance Of Capital Stock is expected to rise to about 67.4 M this year, although the value of Selling General Administrative will most likely fall to about 23.8 M.
 2021 2022 2023 2024 (projected)
Reconciled Depreciation974K1.5M2.5M2.6M
Total Operating Expenses86.1M116.8M123.6M68.1M

Stoke Therapeutics fundamental ratios Correlations

0.770.720.990.560.990.79-0.94-0.740.840.950.790.810.311.00.890.570.950.850.950.640.990.691.00.671.0
0.770.920.680.690.710.94-0.57-0.840.750.570.940.910.50.740.90.720.880.950.880.790.680.780.760.840.72
0.720.920.590.850.650.98-0.52-0.910.630.520.970.930.220.680.910.870.880.980.880.910.590.850.70.840.66
0.990.680.590.440.990.68-0.96-0.640.840.970.690.720.330.990.820.440.890.750.890.521.00.60.990.581.0
0.560.690.850.440.490.81-0.45-0.950.450.410.810.77-0.070.530.751.00.70.810.730.990.440.940.550.870.5
0.990.710.650.990.490.74-0.97-0.690.860.980.740.760.310.990.860.50.930.790.930.560.990.650.990.631.0
0.790.940.980.680.810.74-0.6-0.920.760.611.00.980.370.760.940.830.930.990.930.870.680.870.780.890.73
-0.94-0.57-0.52-0.96-0.45-0.97-0.60.63-0.79-1.0-0.6-0.63-0.16-0.95-0.77-0.43-0.84-0.67-0.85-0.49-0.96-0.61-0.95-0.54-0.96
-0.74-0.84-0.91-0.64-0.95-0.69-0.920.63-0.69-0.6-0.92-0.9-0.18-0.71-0.89-0.94-0.86-0.91-0.88-0.97-0.64-0.99-0.72-0.96-0.69
0.840.750.630.840.450.860.76-0.79-0.690.790.760.830.640.840.870.430.850.750.850.520.840.680.840.750.84
0.950.570.520.970.410.980.61-1.0-0.60.790.610.640.180.960.770.40.850.680.850.470.970.570.950.510.96
0.790.940.970.690.810.741.0-0.6-0.920.760.610.990.370.760.940.830.930.990.930.870.690.870.780.890.74
0.810.910.930.720.770.760.98-0.63-0.90.830.640.990.450.780.950.780.930.960.930.830.720.860.790.890.76
0.310.50.220.33-0.070.310.37-0.16-0.180.640.180.370.450.30.35-0.070.320.30.310.030.330.180.30.390.3
1.00.740.680.990.530.990.76-0.95-0.710.840.960.760.780.30.870.540.930.820.940.60.990.661.00.641.0
0.890.90.910.820.750.860.94-0.77-0.890.870.770.940.950.350.870.750.970.960.970.810.820.850.880.850.85
0.570.720.870.441.00.50.83-0.43-0.940.430.40.830.78-0.070.540.750.710.830.730.990.440.920.560.860.51
0.950.880.880.890.70.930.93-0.84-0.860.850.850.930.930.320.930.970.710.961.00.770.890.80.940.790.92
0.850.950.980.750.810.790.99-0.67-0.910.750.680.990.960.30.820.960.830.960.960.870.750.860.830.860.8
0.950.880.880.890.730.930.93-0.85-0.880.850.850.930.930.310.940.970.731.00.960.790.890.830.940.810.92
0.640.790.910.520.990.560.87-0.49-0.970.520.470.870.830.030.60.810.990.770.870.790.520.950.620.90.58
0.990.680.591.00.440.990.68-0.96-0.640.840.970.690.720.330.990.820.440.890.750.890.520.60.990.581.0
0.690.780.850.60.940.650.87-0.61-0.990.680.570.870.860.180.660.850.920.80.860.830.950.60.680.970.64
1.00.760.70.990.550.990.78-0.95-0.720.840.950.780.790.31.00.880.560.940.830.940.620.990.680.651.0
0.670.840.840.580.870.630.89-0.54-0.960.750.510.890.890.390.640.850.860.790.860.810.90.580.970.650.62
1.00.720.661.00.51.00.73-0.96-0.690.840.960.740.760.31.00.850.510.920.80.920.581.00.641.00.62
Click cells to compare fundamentals

Stoke Therapeutics Account Relationship Matchups

Stoke Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets228.8M297.9M238.9M256.1M228.3M213.7M
Other Current Liab3.4M8.9M13.2M13.4M11.8M8.7M
Total Current Liabilities4.1M11.4M17.1M31.4M30.8M15.9M
Total Stockholder Equity224.4M286.1M217.8M184.8M159.6M184.9M
Other Liab221K342K3.9M37.1M42.7M44.8M
Net Tangible Assets224.4M286.1M217.8M184.8M212.6M186.4M
Property Plant And Equipment Net2.5M3.8M9.1M11.4M12.4M6.4M
Net Debt(222.5M)(287.2M)(143.4M)(111.2M)(189.4M)(198.8M)
Retained Earnings(58.0M)(110.3M)(196.1M)(297.2M)(401.8M)(381.8M)
Accounts Payable751K1.5M2.4M766K1.7M1.3M
Cash222.5M287.3M144.9M113.6M191.4M167.7M
Non Current Assets Total2.7M4.0M9.6M12.0M13.0M6.8M
Other Assets205K1.3M248.5M569K654.4K621.6K
Cash And Short Term Investments222.5M287.3M219.8M229.6M201.4M199.2M
Common Stock Shares Outstanding18.0M33.5M36.7M38.9M44.0M32.6M
Liabilities And Stockholders Equity228.8M297.9M238.9M256.1M228.3M213.7M
Non Current Liabilities Total221K422K3.9M39.8M38.0M39.9M
Capital Surpluse282.5M396.4M414.0M483.2M555.6M315.1M
Other Current Assets3.3M6.6M9.3M13.9M13.9M7.5M
Other Stockholder Equity282.5M396.4M414.0M483.2M561.4M358.4M
Total Liab4.3M11.8M21.1M71.2M68.8M72.2M
Net Invested Capital224.4M286.1M217.8M184.8M159.6M184.9M
Property Plant And Equipment Gross2.5M3.8M9.1M11.4M19.1M20.1M
Total Current Assets226.0M293.9M229.2M244.1M215.3M206.9M
Non Current Liabilities Other221K422K3.9M3.0M4.9M5.1M
Net Working Capital221.9M282.5M212.1M212.7M184.5M191.0M
Property Plant Equipment2.5M2.7M9.1M6.7M7.7M4.1M
Net Receivables281K6K132K588K64K60.8K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Stoke Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stoke Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stoke Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Stoke Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.08)
Revenue Per Share
0.328
Quarterly Revenue Growth
0.479
Return On Assets
(0.28)
Return On Equity
(0.52)
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.